Online First

ASCO 2025

SABCS 2024

ESMO 2024

Organ-preserving regimens in rectal cancer

Presented By
Dr Alessio Amatu, Niguarda Cancer Center, Italy; Dr Syrine Ben Dhia, Antoine Lacassagne Center, France
Trial
NO-CUT, OPERA
Conference
ESMO 2024
Type
Peer-reviewed article

177Lu-PSMA effective both in mCRPC and mHSPC

Presented By
Prof. Oliver Sartor, Tulane University, LA, USA; Dr Arun Azad, Peter MacCallum Cancer Centre, Australia
Trial
SPLASH, UpFrontPSMA
Conference
ESMO 2024
Type
Peer-reviewed article

Final OS for CONTACT-02 trial in mCRPC

Presented By
Prof. Neeraj Agarwal, Huntsman Cancer Institute; University of Utah, UT, USA
Trial
Phase 3, CONTACT-02
Conference
ESMO 2024
Type
Peer-reviewed article

ESMO GI 2024

OS benefit in ARMANI, but is it worth it?

Presented By
Dr Giovanni Randon, Fondazione IRCCS Istituto Nazionale dei Tumori, Italy
Trial
Phase 3, ARMANI
Conference
ESMO GI 2024
Type
Peer-reviewed article

ASCO 2024

ASCO GI 2024

SABCS 2023

ESMO 2023

ASCO 2023

SABCS 2022

ASCO GI 2023

ESMO 2022

WCLC 2022

ASCO 2022

ELCC 2022

Rare EGFR mutations as oncogenic drivers

Presented By
Dr Alfredo Addeo (University Hospital of Geneva, Switzerland) and Dr Giulia Pasello (Veneto Institute of Oncology, Italy)
Conference
ELCC 2022
Type
Peer-reviewed article

ASCO GU 2022

Darolutamide improves OS in mHSPC

Presented By
Dr Matthew Smith, Massachusetts General Hospital Cancer Center, MA, USA
Trial
Phase 3, ARASENS
Conference
ASCO GU 2022
Type
Peer-reviewed article

ASCO GI 2022

SABCS 2021

ESMO 2021

Novel conjugate meets primary endpoint

Presented By
Dr Cristina Saura, Vall d’Hebron Institute of Oncology, Spain
Trial
Phase 3, TULIP
Conference
ESMO 2021
Type
Peer-reviewed article

Updated results of SECOMBIT trial

Presented By
Prof. Paolo Ascierto, Istituto Nazionale Tumori "Fondazione Pascale", Italy
Trial
Phase 2, SECOMBIT
Conference
ESMO 2021
Type
Peer-reviewed article

Mutational analyses are predictive in malignant lymphomas

Presented By
Dr Ismael FernƔndez-Miranda, Institute of Sanitary Investigation Puerta de Hierro, Spain & Dr Shan-Shan Li, Hospital of Sun Yat-sen University, China
Conference
ESMO 2021
Type
Peer-reviewed article

Adequate response to SARS-CoV-2 vaccine in cancer patients

Presented By
Dr Sjoukje Oosting, University Medical Center Groningen, the Netherlands & Dr Scott Shepherd, Royal Marsden NHS Foundation Trust, UK
Trial
VOICE & CAPTURE
Conference
ESMO 2021
Type
Peer-reviewed article

WCLC 2021

ASCO 2021

Long-term results from ground-breaking melanoma trials

Presented By
Dr Jedd Wolchok (Memorial Sloan Kettering Cancer Center, NY, USA). Prof. Reinhard Dummer (University Hospital Zürich, Switzerland) , Prof. Georgina Long (Melanoma Institute, Australia)
Trial
CheckMate 067, COLUMBUS, ABC
Conference
ASCO 2021
Type
Peer-reviewed article

ASCO GI 2021

ESMO 2020

ASCO 2020

ES-SCLC: pembrolizumab KEYNOTE-604 data

Presented By
Dr Charles M. Rudin, Memorial Sloan Kettering Cancer Center, USA
Trial
Phase 3, KEYNOTE-604
Conference
ASCO 2020
Type
Peer-reviewed article

Thoracic cancers versus COVID-19

Presented By
Leora Horn, Vanderbilt-Ingram Cancer Center, USA
Trial
TERAVOLT
Conference
ASCO 2020

BCC 2019

Life style

Conference
BCC 2019
Type
Peer-reviewed article

ELCC 2019

I-O monotherapy

Presented By
Prof. Martin Reck, Airway Research Center North, Grosshansdorf, Germany
Trial
CheckMate 026, Keynote-024, Checkmate 227, MYSTIC, B-F1RST
Conference
ELCC 2019
Type
Peer-reviewed article

Incidence and local treatment

Presented By
Prof. Michael Weller, University Hospital Zurich, Switzerland
Conference
ELCC 2019
Type
Peer-reviewed article

Combo I-O plus chemotherapy

Presented By
Dr Luis Paz-Ares, Complutense University of Madrid, Spain
Trial
Keynote-189, Impower-132
Conference
ELCC 2019
Type
Peer-reviewed article

Brain irradiation as treatment option

Presented By
Prof. Corinne Faivre-Finn, The Christie NHS Foundation Trust and University of Manchester, UK
Trial
Phase 3, QUARTZ
Conference
ELCC 2019
Type
Peer-reviewed article

Other I-O combinations

Presented By
Prof. Solange Peters, Lausanne University Hospital and Ludwig Institute, Switzerland
Trial
IMpower 150
Conference
ELCC 2019

Experiences from France

Presented By
Dr Benjamin Besse, Institut Gustave Roussy, France
Conference
ELCC 2019
Type
Peer-reviewed article

Predictive diagnostics for I-O

Presented By
Dr Enriqueta Felip, Vall d’Hebron University Hospital, Spain
Trial
Phase 3, BFAST
Conference
ELCC 2019
Type
Peer-reviewed article

Electromagnetic navigation bronchoscopy

Presented By
Dr Kelvin Lau, St Bartholomew’s Hospital, London, United Kingdom
Trial
NAVIGATE
Conference
ELCC 2019
Type
Peer-reviewed article

Genomic and immune profiling

Presented By
Dr Ke-Zhong Chen, Peking University People’s Hospital, Beijing, China
Conference
ELCC 2019
Type
Peer-reviewed article

Treatment options in early NSCLC

Presented By
Dr Walter Weder, Dr Raffaele Califano
Trial
CALGB 9633
Conference
ELCC 2019
Type
Peer-reviewed article

Immunotherapy in SCLC: trial data

Presented By
Dr Enriqueta Felip, Vall d’Hebron University Hospital, Spain
Trial
CA184-156, CheckMate-451, CASPIAN, Keynote-604, Checkmate 032
Conference
ELCC 2019
Type
Peer-reviewed article

Systemic therapy of brain metastases

Presented By
Dr Natasha Leighl, Dr Edrune Arriola Aperribay
Trial
Phase 3, FLAURA, ALEX, ALTA-1L, AURA3
Conference
ELCC 2019
Type
Peer-reviewed article

WCLC 2019

ESMO 2019

Ceritinib in ALK+ NSCLC brain metastases

Presented By
Dr Laura Quan Man Chow, University of Texas at Austin, USA
Trial
Phase 2, ASCEND-7
Conference
ESMO 2019
Type
Peer-reviewed article

Long-term data from CheckMate 067

Presented By
Prof. James Larkin, Royal Marsden NHS Foundation Trust, London, UK
Trial
Phase 3, CheckMate 067
Conference
ESMO 2019
Type
Peer-reviewed article

Third-line in mCRPC: CARD trial

Presented By
Prof. Ronald De Wit, Erasmus University Rotterdam, the Netherlands
Trial
CARD
Conference
ESMO 2019
Type
Peer-reviewed article

SABCS 2019

ASCO 2019

WCLC 2018

ESMO WCGIC 2018

ESMO 2018

ASCO 2017

EASL 2017

ESMO 2017